RecruitingNCT06991517

A Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm

A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve


Sponsor

World Health Research Inc.

Enrollment

290 participants

Start Date

May 13, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to learn what effects the ABC Bicuspid Sizing Algorithm has on the clinical outcomes of patients with bicuspid aortic stenosis after having a transcatheter aortic valve replacement (TAVR) using the Sapien 3 valve. The main questions the study aims to answer are: 1. Does the ABC Bicuspid Sizing Algorithm increase the technical success at exit from the procedure room? 2. Does the ABC Bicuspid Sizing Algorithm increase the device success at 30 days after the procedure? Participants already being evaluated for a TAVR as part of their regular medical care for bicuspid aortic stenosis will have their diagnostic images assessed using the ABC Bicuspid Sizing Algorithm to help determine their procedure type and valve size. They will have visits 30 days and annually till 5 years after their procedure.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying The ABC Bicuspid Sizing Algorithm for people with aortic stenosis. The study is currently recruiting participants at 21 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThe ABC Bicuspid Sizing Algorithm

The ABC Bicuspid Sizing Algorithm is a valve sizing algorithm. It guides operators' evaluations of CT scans, helping inform (1) treatment allocation between TAVR and surgical aortic valve replacement, and (2) valve choice for patients undergoing TAVR. In select cases, the algorithm will suggest gated CT evaluation or artificial intelligence-based simulation models be used to further evaluate the risk of the planned valve size and deployment volume. The operators will consider the findings of the ABC Bicuspid Sizing Algorithm as well as other clinical factors when making their final treatment decisions.


Locations(20)

North Shore Private Hospital

St Leonards, New South Wales, Australia

Royal North Shore Hospital

St Leonards, New South Wales, Australia

The Prince Charles Hospital

Chermside, Queensland, Australia

St Andrew's War Memorial Hospital

Spring Hill, Queensland, Australia

The Alfred

Melbourne, Victoria, Australia

Fiona Stanley Hospital

Murdoch, Western Australia, Australia

Foothills Medical Centre

Calgary, Alberta, Canada

NovaScotia Health Authority- Halifax Infimary

Halifax, NovaScotia, Canada

Hamilton General Hospital

Hamilton, Ontario, Canada

Southlake Regional Health Centre

Newmarket, Ontario, Canada

University of Ottawa Heart Institute

Ottawa, Ontario, Canada

St. Michael's Hospital

Toronto, Ontario, Canada

Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

Québec, Quebec, Canada

Fundación Cardioinfantil - LaCardio

Bogotá, Colombia

Hospital San Juan de Dios

San José, Provincia de San José, Costa Rica

Centro Médico Nacional Siglo XXI

Mexico City, Mexico

Wellington Regional Hospital

Newtown, Wellington Region, New Zealand

Christchurch Hospital

Christchurch, New Zealand

National Heart Centre Singapore

Singapore, Singapore

Ramathibodi Hospital

Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06991517


Related Trials